LeafNLP Demos
Back to explore

Report #2873664

Received Nov 19, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
Nov 17, 2025
Onset
Nov 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKDL32G—

Symptoms (1)

Expired product administered

Symptom narrative

inadvertently an expired antigen of Arexvy was administered to a patient; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 75-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number DL32G, expiry date 03-NOV-2025) for prophylaxis. On 17-NOV-2025, the patient received Arexvy. On 17-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: inadvertently an expired antigen of Arexvy was administered to a patient). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 17-NOV-2025 Pharmacist reported that they inadvertently administered expired antigen of Arexvy to a patient, also stated that the adjuvant was not expired.